SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-008534
Filing Date
2009-05-11
Accepted
2009-05-11 16:15:29
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y01643e10vq.htm 10-Q 185920
2 EX-31.1 y01643exv31w1.htm EX-31.1 8525
3 EX-31.2 y01643exv31w2.htm EX-31.2 8512
4 EX-32.1 y01643exv32w1.htm EX-32.1 3308
5 EX-32.2 y01643exv32w2.htm EX-32.2 3324
  Complete submission text file 0000950123-09-008534.txt   211246
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 09815167
SIC: 2836 Biological Products, (No Diagnostic Substances)